Bogle Investment Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-13,500
| Closed | -$112K | – | 246 |
|
|
2020
Q2 | $112K | Buy |
+13,500
| New | +$112K | 0.02% | 301 |
|
|
2018
Q4 | – | Sell |
-32,385
| Closed | -$599K | – | 343 |
|
|
2018
Q3 | $599K | Sell |
32,385
-80,960
| -71% | -$1.5M | 0.04% | 232 |
|
|
2018
Q2 | $2.59M | Buy |
113,345
+8,639
| +8% | +$197K | 0.19% | 133 |
|
|
2018
Q1 | $2.98M | Sell |
104,706
-91,326
| -47% | -$2.6M | 0.22% | 122 |
|
|
2017
Q4 | $4.14M | Buy |
196,032
+32,180
| +20% | +$679K | 0.3% | 103 |
|
|
2017
Q3 | $2.98M | Buy |
+163,852
| New | +$2.98M | 0.2% | 138 |
|